about
The miRacle in Pancreatic Cancer by miRNAs: Tiny Angels or Devils in Disease ProgressionManaging Pancreatic Adenocarcinoma: A Special Focus in MicroRNA Gene TherapyMicroRNAs as diagnostic and prognostic biomarkers in colorectal cancerMicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate CancerMicroRNAs: Novel Crossroads between Myeloma Cells and the Bone Marrow MicroenvironmentSurvivin and Tumorigenesis: Molecular Mechanisms and Therapeutic StrategiesMicroRNAs in multiple myeloma and related bone diseaseTherapies targeting cancer stem cells: Current trends and future challengesImpact of miRNAs on cardiovascular agingPromiscuous Effects of Some Phenolic Natural Products on Inflammation at Least in Part Arise from Their Ability to Modulate the Expression of Global Regulators, Namely microRNAsRegulatory mechanisms of microRNAs in lung cancer stem cellsUnraveling the Anticancer Effect of Curcumin and ResveratrolMicroRNA-106b promotes colorectal cancer cell migration and invasion by directly targeting DLC1Registered report: the microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44Pigmy MicroRNA: surveillance cops in Therapies kingdomMicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasionThe diagnostic role of microRNA-34a in breast cancer: a systematic review and meta-analysis.Low Expression of Circulating MicroRNA-34c is Associated with Poor Prognosis in Triple-Negative Breast CancerVerification of microRNA expression in human endometrial adenocarcinoma.Creating a Biomarker Panel for Early Detection of Chemotherapy Related Cardiac Dysfunction in Breast Cancer PatientsMicroRNA regulation and therapeutic targeting of survivin in cancer.Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasmsSirt7 promotes gastric cancer growth and inhibits apoptosis by epigenetically inhibiting miR-34a.Development of small RNA delivery systems for lung cancer therapy.MicroRNA network changes in the brain stem underlie the development of hypertensionMiR-34c-3p suppresses the proliferation and invasion of non-small cell lung cancer (NSCLC) by inhibiting PAC1/MAPK pathway.Differentially Expressed MicroRNAs in Meningiomas Grades I and II Suggest Shared Biomarkers with Malignant Tumors.MicroRNA-34b mediates hippocampal astrocyte apoptosis in a rat model of recurrent seizuresThe miR-34a-5p promotes the multi-chemoresistance of osteosarcoma via repression of the AGTR1 gene.Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo.A MicroRNA Screen Identifies the Wnt Signaling Pathway as a Regulator of the Interferon Response during Flavivirus Infection.Delivery of miR-34a by chitosan/PLGA nanoplexes for the anticancer treatment of multiple myeloma.Altered regulation of miR-34a and miR-483-3p in alcoholic hepatitis and DDC fed mice.The Significance of miR-34a Expression in Endometrial Carcinogenesis: Correlation With Expression of p16 and Ki-67 Proteins in Endometrial Cancers.MicroRNAs in vascular tissue engineering and post-ischemic neovascularizationmiR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer.Small and Long Non-Coding RNAs: Novel Targets in Perspective Cancer Therapy.Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125bThe orphan nuclear receptor NR4A2 is part of a p53-microRNA-34 network.HPV E6/p53 mediated down-regulation of miR-34a inhibits Warburg effect through targeting LDHA in cervical cancer.
P2860
Q26744831-BFD47539-A0FE-4842-B92D-50FF1662AA46Q26749037-BE303D5B-4A2D-4314-8FA2-AB3F1CDD5F32Q26751780-64361C3E-26B6-4638-87D3-EEB63E9AEF4BQ26751983-FC7622A1-101E-406E-BC68-7803BDF4D47CQ26765477-388751FD-6817-4AB8-92D0-C173CA2DB9E2Q26766250-F51101D0-864C-4056-A194-C14F4F349FC5Q26770478-8C3ADFF2-807D-4D8A-A538-4FE7F300938EQ26777880-C354CCAF-7967-4FAD-AD13-52DE87FE1CC2Q26778101-33A22FCB-4FF1-4B75-A39B-BDE6DE4A9257Q28066929-0E7294FD-BB57-45A1-AD93-B04716F4E744Q28072716-F18F778F-7D94-41AC-8E27-8978AFE7CD1DQ28073155-D0A558D5-B086-4C01-999B-CF9D878BA8A4Q28384675-31D94E0B-946D-4552-864D-195BD3A87F69Q28645941-E8E48352-AEB7-4259-8E5E-5A5F4949544FQ28818470-5707DF29-8ECF-4CE6-B5BA-D0F2E4DA5D3DQ30352893-DFDD234B-E9F9-4922-AE57-CC26655FD2D2Q33618617-BD2B40D1-65A2-4908-B217-0001353B712BQ33734951-B17663C6-09FF-4EF1-9C34-BB957D1B48D7Q33816414-8F6B8DDE-F237-4C6D-B94F-68C58CC0CAC5Q33816471-54974B9A-E59C-4C9A-8664-BA7620B05CC1Q34991312-A6DE8C11-1735-4C96-A9F9-93152697F761Q35127713-81E56F17-F3DE-4845-9B77-AFACB48D0843Q35356744-3EE6F40F-4E9C-4037-A47C-E624CED90EDFQ35380932-BD3B12FB-6D14-426F-B3BC-33F878DDA1DBQ35679000-9F77BE37-3A88-4275-80B0-3ED8C977C8F9Q35918962-C3469FED-9BB1-488B-B74E-856278A97B09Q35947699-1ED3A6DC-2AC9-4AD1-A4D2-249E63AA6F29Q36101756-7E453F9A-EF40-4138-A200-1DA61D87CDAAQ36245752-1EBB98D9-6FD1-4DFD-8478-F94652D7942BQ36254566-8AB82184-98EB-4764-ACEE-8515C5CFF1F2Q36266860-68D6813D-A1CD-4E1A-8CD2-624054C5E68EQ36334131-1A5A2C21-30C5-4770-94E5-E0D82BA0635CQ36372824-E3D9E213-40B2-49A7-9830-B4812934F3FCQ36426116-394879FC-F292-4C37-99A9-170660EA7905Q36506217-A36D0B11-BFE2-4E27-AD84-60E4F10798E0Q36586444-FAE7EF98-8B3A-4641-A73C-8DE05E2DE1EEQ36608200-B3CA1A38-DFFF-498F-8E80-AFBF283F94B5Q36782461-3573D54F-7353-471F-890B-E255CF7342AAQ36845699-5C31D7B2-3D7C-427F-8C2E-8E979AD09AE6Q36878717-489C3D44-DA36-4461-9BC5-E5CED0E97E97
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Mir-34: a new weapon against cancer?
@en
type
label
Mir-34: a new weapon against cancer?
@en
prefLabel
Mir-34: a new weapon against cancer?
@en
P2093
P2860
P50
P356
P1476
Mir-34: a new weapon against cancer?
@en
P2093
Ammad Ahmad Farooqi
Annamaria Gullà
Giuseppe De Rosa
Pierfrancesco Tassone
Pierosandro Tagliaferri
Virginia Campani
P2860
P356
10.1038/MTNA.2014.47
P577
2014-09-23T00:00:00Z